ArticleFrontiers in immunology2022

Identification of New Prognostic Markers and Therapeutic Targets for Non-Muscle Invasive Bladder Cancer: HER2 as a Potential Target Antigen.

Han Kyu Chae et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.